Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Euro nano opinion

This article was originally published in The Tan Sheet

Executive Summary

The European Food Safety Authority's Scientific Committee opens for comment Oct. 17 a draft scientific opinion on the potential risks of nanotechnologies for food. The opinion, requested by the European Commission to help develop appropriate legislation, says that established risk assessment approaches apply to nanoscience, though "it is generally not possible to extrapolate the potential toxicity of [engineered nanomaterials] from information on dissolved or macroscale chemicals." EFSA will accept comments until Dec. 1 at The EC advised European Union members to avoid clinical research on nanoparticles in food and personal care products until it learns more about their biological and environmental effects (2"The Tan Sheet" Feb. 25, 2008, p. 12)

You may also be interested in...

U.K. commission on nano

There is no evidence of environmental or health risks from nanomaterials, and thus no need to ban nanotechnology, the U.K.'s Royal Commission on Environmental Pollution says in a Nov. 12 report. The advisory panel calls for more testing on nanoparticles' functionality, a research program and government flexibility to address nanotechnology and other nascent fields. RCEP Chairman John Lawton calls for extending the coverage of the European Union's REACH chemical regulation to nanomaterials, as "the rate of innovation in this sector far outstrips our capacity to respond to the risks." The European Commission has advised EU members not to research nanoparticles in food and personal care items until more risk assessments are completed (1"The Tan Sheet" Oct. 20, 2008, In Brief)

EC Advises Against Studying Nano-Products In Humans Until Risks Are Known

Researchers should avoid clinical studies on nano-based personal care products until more is known about their long-term effects, according to the European Commission

TTS Pharma Wants To Bring First Legal CBD Oil To The UK

TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts